Ventricular fibrillation and myocardial necrosis after transient ischemia. Effect of treatment with oxygen, procainamide, reserpine, and propranolol.
D000818:Animals; D003327:Coronary Disease / Q000150:complications*; D004285:Dogs; D007269:Injections, Intra-Arterial; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D009203:Myocardial Infarction / Q000188:drug therapy / Q000209:etiology / Q000473:pathology / Q000628:therapy*; D010102:Oxygen Inhalation Therapy; D011342:Procainamide / Q000008:administration & dosage / Q000627:therapeutic use*; D011433:Propranolol / Q000008:administration & dosage / Q000627:therapeutic use*; D012110:Reserpine / Q000008:administration & dosage / Q000627:therapeutic use*; D014693:Ventricular Fibrillation / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*
D012110:Reserpine; D011433:Propranolol; D011342:Procainamide